IP-118

N/A

Report date: 2026/05/09 20:00:18

Base Information

Drug NameIP-118
Drug Alias NameIP-118IP118
ClassificationOther
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsMetabolic DiseasesMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedimmune LlcMedimmune LtdAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesMedimmune LtdMedimmune Llc
Inactive CompaniesN/A
Active IndicationsMetabolic DiseasesMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A